# Biaxin Based Antibiotic Therapy in Previously Untreated, Advanced Stage Indolent Lymphoma

> **NCT00461084** · — · COMPLETED · sponsor: **Memorial Sloan Kettering Cancer Center** · enrollment: 36 (actual)

## Conditions studied

- Lymphoma

## Interventions

- **DRUG:** BIAXIN (CLARITHROMYCIN)
- **DRUG:** Biaxin (clarithromycin)

## Key facts

- **NCT ID:** NCT00461084
- **Lead sponsor:** Memorial Sloan Kettering Cancer Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2007-04
- **Primary completion:** 2014-09
- **Final completion:** 2014-09
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2014-09-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00461084

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00461084, "Biaxin Based Antibiotic Therapy in Previously Untreated, Advanced Stage Indolent Lymphoma". Retrieved via AI Analytics 2026-07-28 from https://api.ai-analytics.org/clinical/NCT00461084. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*